Labiotech.eu

needle free blood sugar testing graphene patch

More News! 12 Apr 2018

Graphene Skin Patch Measures Blood Sugar Without a Needle

Researchers in the UK have developed a skin patch that measures blood sugar levels without the prick of a needle by pulling fluid out from between hair follicles. The technology could be used for both type 1 and type 2 diabetes patients. Diabetes is a major global health problem, with the World Health Organization stating 422 […]

April 12, 2018 - 2 minutesmins - By Alexander Burik

Alexion Pharmaceutical Wilson Therapeutics 2

News and Trends 11 Apr 2018

Alexion Acquires Swedish Treatment for Wilson’s Disease

Alexion Pharmaceutical intends to buy Wilson Therapeutics for nearly $1Bn. Wilson is developing a first-in-class treatment for Wilson’s disease, a rare disorder that can lead to severe liver and brain damage. Alexion Pharmaceuticals, one of the most successful companies in rare diseases and known for selling one of the most expensive drugs in the world, […]

April 11, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 11 Apr 2018

Dutch Organs-on-Chips Raises $20.5M in Series B Financing

MIMETAS, a Dutch biotech, has raised a Series B financing round to continue developing its organ-on-a-chip platform, which could remove the need to use animals in preclinical drug testing. MIMETAS, based in Leiden, has secured $20.5M (€17M) in Series B financing from investors in Asia and Europe. The company will use the funding to develop its organ-on-a-chip […]

April 11, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 11 Apr 2018

French CAR-T Developer Raises $164M Despite a Challenging Road

Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in clinical trials, despite having mixed results in the technology’s development up until now. Cellectis, based in Paris, has closed a follow-on offering on NASDAQ, raising a total of around $164M (€132M). The funding will be used to further continue clinical development […]

April 11, 2018 - 3 minutesmins - By Alexander Burik

Niels Riedemann InflaRx Cover Image Compressed

Interview 11 Apr 2018

Forget Humira, a New Generation of Inflammation Treatments is on the Horizon

Millions of people worldwide suffer from inflammatory diseases, and many are still waiting for effective treatments. A German company, InflaRx, might have one. We spoke to its founder and CEO, Niels Riedemann, to get the whole story about the company’s technology and its recent $106M IPO on NASDAQ. It might be hard to believe, but […]

April 11, 2018 - 5 minutesmins - By Alexander Burik

News and Trends 10 Apr 2018

Microbes Come to the Rescue to Reduce Hospital Waste

Hospital waste management is no laughing matter, given that one hospital bed can produce up to 0.5 kg of waste per day. A Dutch technology is using microbes to optimize the process with anaerobic digestion. We look to hospitals and our healthcare systems at large for treatment and reassurance when we are sick, but it […]

April 10, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 10 Apr 2018

New Skin Care Products Use Plant Pigment Made By Bacteria

Deinove is launching a new compound made from a plant pigment that could be used in anti-aging and make-up products. Deinove, based in Montpellier, is the first company to produce pure phytoene, an anti-aging cosmetic compound, through bacterial fermentation. The company plans to launch an anti-aging and cosmetic skin care product, Phyt-N-Resist, made from their […]

April 10, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 6 Apr 2018

Spanish Biotech Uses Microbes to Make Biofuels, Food and Detergents

Today, we’re in Granada, Spain, to visit Neol Bio. The biotech recycles waste to produce oils for biofuels, nutritional supplements and cleaning detergents by culturing microorganisms with waste. Mission: Neol Bio develops sustainable ways of producing oils for a wide variety of applications, from food supplements to cleaning detergents and bioenergy. The company uses high-throughput screening to […]

April 6, 2018 - 2 minutesmins - By Alexander Burik

OSE Immunotherapeutics Boehringer Ingelheim

News and Trends 5 Apr 2018

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has set its eyes on a new type of checkpoint inhibitor being developed by the French biotech. OSE Immunotherapeutics has entered a global license and collaboration deal with Boehringer Ingelheim for the development of OSE-172, a checkpoint inhibitor antibody to treat […]

April 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 5 Apr 2018

French Crossover Fund Raises €275M to Invest in Medical Biotechs

Sofinnova Partners has launched a crossover fund focusing on European companies to support medical biotechs across all funding stages, from seed to late stage. Sofinnova Partners, the largest French biotech VC, has launched a new fund called Sofinnova Crossover I to invest in the biopharmaceutical and medical device sectors. According to Sofinnova, the €275M fund […]

April 5, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 4 Apr 2018

First Rapid Molecular Diagnostics Test for Lung Infections Approved in the US

Curetis is the first company to receive FDA approval to market a molecular diagnostic test for lung infections in the US. The test reduces the time taken to reach a diagnosis from several days under five hours. The FDA has given Curetis, a German biotech, the green light to launch its first-in-class Unyvero platform for diagnosing lung infections […]

April 4, 2018 - 3 minutesmins - By Alexander Burik

genesight gene therapy blindness placebo

News and Trends 4 Apr 2018

Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial

GenSight has demonstrated that its gene therapy for a rare disease causing blindness can significantly improve the vision of patients. But so does the placebo. GenSight Biologics has released the results of a Phase III clinical trial testing its gene therapy GS010 in patients suffering from Leber hereditary optic neuropathy (LHON), a rare mitochondrial disease […]

April 4, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Graphene Skin Patch Measures Blood Sugar Without a Needle

Alexion Acquires Swedish Treatment for Wilson’s Disease

Dutch Organs-on-Chips Raises $20.5M in Series B Financing

French CAR-T Developer Raises $164M Despite a Challenging Road

Forget Humira, a New Generation of Inflammation Treatments is on the Horizon

Microbes Come to the Rescue to Reduce Hospital Waste

New Skin Care Products Use Plant Pigment Made By Bacteria

Spanish Biotech Uses Microbes to Make Biofuels, Food and Detergents

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

French Crossover Fund Raises €275M to Invest in Medical Biotechs

First Rapid Molecular Diagnostics Test for Lung Infections Approved in the US

Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!